Leap Therapeutics is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.
June 13, 2018Leap Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference
May 11, 2018Leap Therapeutics Reports First Quarter 2018 Financial Results
April 16, 2018Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting
There are currently no events scheduled.
as of 3:59 PM ETJul 20, 2018
Data provided by Nasdaq. Minimum 15 minutes delayed.